Q2 2026 Earnings Call Transcript January 8, 2026 Neogen Corporation beats earnings expectations. Reported EPS is $0.1, ...

44 th Annual J.P. Morgan Healthcare Conference Format: Company presentation Date: Thursday, January 15, 2026 Time: 12:00 PM PT Location: California East at The Westin St. Francis ...

Product Revenues, Net Expected in the Range of $805 Million to $825 Million –– Jornay PM® Net Revenue Expected in the Range of $190 Million to ...

TARRYTOWN, N.Y., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 44 th Annual J.P. Morgan Healthcare Conference on Monday, January ...

A Columbia University public health instructor ranted to 400 incoming students about how the school’s prominent Jewish donors only made their gifts to “launder blood money” and denied the existence of ...

LOS ANGELES, CA, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a global leader in relapsed/refractory AL Amyloidosis, today announced ...

Well, this is a strange one. Just minutes before it was set to deliver its financial results for the first half of its 2025-26 fiscal year, Ubisoft mashed the brakes on the whole thing, postponing the ...

Financial services firms have increased their presence in the state of Texas in recent years as they diversify their strategic footprint beyond the traditional financial hub of New York City's Wall ...

INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, will be showcased in three presentations, including new Phase 1 monotherapy and combination data in ...

Washington, DC: The International Monetary Fund (IMF) released the results of the 2025 Financial Access Survey (FAS), accompanied by the report "Financial Access Survey: Fintech, a Catalyst for ...

A presentation about the many different types of fraud that can impact college students was given in Lumpkin Hall on Oct 21. Jason Donnelly, the vice president and treasury management relationship ...

Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with ...